Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00613015 · ClinicalTrials.gov registry record · Phase 2

Stress and Medication Effects on Cocaine Cue Reactivity

A Phase 2 study, sponsored by Medical University of South Carolina.

Completed
Registry status
Phase 2
Development phase
109
Enrollment target

NCT00613015 is a Phase 2 study that has completed, run by Medical University of South Carolina. The registered enrollment target is 109 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00613015, a Phase 2 study, has completed, sponsored by Medical University of South Carolina.

COMPLETED
Registry status
Phase 2
Development phase
109 participants
Enrollment target

Study Summary

Stressful situations and cues associated with cocaine can lead to craving in cocaine dependent individuals. The purpose of this study is to determine whether guanfacine or modafinil are effective in reducing stress and cue induced craving in cocaine dependent individuals.

Interventions

  • DRUG Placebo
  • DRUG Modafinil
  • DRUG Guanfacine

Trial Details

FieldValue
Enrollment Target 109 participants
Start Date 2008-05
Est. Completion 2012-07
Phase Phase 2

What the Registry Record Tells You About NCT00613015

The ClinicalTrials.gov registry entry for NCT00613015 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 109 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.

NCT00613015 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00613015 about?

NCT00613015 is a clinical study titled "Stress and Medication Effects on Cocaine Cue Reactivity". Stressful situations and cues associated with cocaine can lead to craving in cocaine dependent individuals. The purpose of this study is to determine whether guanfacine or modafinil are effective in reducing stress and cue induced craving in cocaine dependent individuals.

What is the current status of trial NCT00613015?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 109 participants. The study started on 2008-05. Estimated completion is 2012-07.

What interventions are being tested in trial NCT00613015?

The interventions under investigation include: Placebo (DRUG), Modafinil (DRUG), Guanfacine (DRUG).

Who is sponsoring clinical trial NCT00613015?

This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.